Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Publishes Data on microRNA-Based Lung Cancer Assay


Rosetta Genomics has published data validating its miRview Lung assay as a means to differentiate between the four main types of lung cancer.

The report appeared online last week in the Journal of Molecular Diagnostics.

The assay is based on the expression levels of eight microRNAs, measured using a quantitative RT-PCR platform.

In the study, the assay was validated on an independent set of 451 samples, more than half of which were pre-operative cytologic samples obtained as fine-needle aspirations or bronchial brushings and washings, Rosetta said.

More than 90 percent of the samples were successfully processed with an overall accuracy of 94 percent — a finding obtained with both pathologic and cytologic samples, which Rosetta said demonstrates the assay's ability to differentiate between squamous cell carcinoma, non-squamous non-small cell lung cancer, carcinoid, and small cell carcinoma.

The publication comes on the heels of the New York State Department of Health's conditional approval of miRview Lung (GWDN 6/26/2012).

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.